Cargando...

Adalimumab for the treatment of Crohn’s disease

INTRODUCTION: Crohn’s disease (CD) is a chronic inflammatory bowel disease characterized by a relapsing-remitting course with trans-mural inflammation of potentially any section of the digestive tract. Adalimumab (ADA) is a subcutaneously administered, recombinant, fully human, IgG1 monoclonal antib...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cassinotti, Andrea, Ardizzone, Sandro, Porro, Gabriele Bianchi
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2727899/
https://ncbi.nlm.nih.gov/pubmed/19707457
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!